Asia-Pacific cancer diagnostics market is expected to grow at a formidable CAGR during the forecast period. The Asia-Pacific cancer diagnostics market is driven by rising prevalence of oncologic cases in the region. Moreover, increase in aging population is positively impacting the growth of market during the forecast period. Also, growing requirement for effective screening tests coupled with new technology developments by key market players are further expected to bolster the growth of market over the next few years.

The Asia-Pacific cancer diagnostics market is segmented based on diagnostic type, technology, application, end-user, company, and region. Based on application, the market can be fragmented into lung cancer, breast cancer, colorectal cancer, prostate cancer, kidney cancer, skin cancer, others. The breast cancer segment is expected to dominate the market during the forecast period on account of increasing number of breast cancer cases in the region. Mammography is the most common screening test employed for breast tumor screening.

Additionally, initiatives taken by certain organizations to spread awareness pertaining to breast cancer as well as benefits of early detection, are further contributing to the segmental growth in upcoming years. Also, available treatment options for breast cancer are also expected to augment the demand in near future.

The major players operating in the Asia-Pacific cancer diagnostics market are Thermo Fisher Scientific, Inc., GE Healthcare (A Subsidiary of General Electric Company), Abbott Laboratories, Inc., Becton, Dickinson and Company, Siemens AG, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Bio Rad Laboratories Inc., Illumina, Inc., Boehringer-Ingelheim International GmbH, and others.

Major companies are developing advanced technologies and launching new products to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnerships, agreements and new developments, in order to expand their geographic reach and to increase their customer base.

Objective of the Study:

  • To analyze and estimate the market size of Asia-Pacific cancer diagnostics market from 2017 to 2020.
  • To estimate and forecast the market size of Asia-Pacific cancer diagnostics market from 2021 to 2027 and growth rate until 2027.
  • To classify and forecast Asia-Pacific cancer diagnostics market based on diagnostic type, technology, application, end-user, company and regional distribution.
  • To identify dominant region or segment in the Asia-Pacific cancer diagnostics market.
  • To identify drivers and challenges for Asia-Pacific cancer diagnostics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in Asia-Pacific cancer diagnostics market.
  • To conduct pricing analysis for Asia-Pacific cancer diagnostics market.
  • To identify and analyze the profiles of leading players operating in Asia-Pacific cancer diagnostics market.
  • To identify key sustainable strategies adopted by market players in Asia-Pacific cancer diagnostics market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of major diagnostic players and hospital chains across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the products and presence of all major players across the globe.

TechSci Research calculated the market size of Asia-Pacific cancer diagnostics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Cancer diagnostic hospitals, diagnostic laboratories and other stakeholders
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to cancer diagnostics

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as major diagnostic players and hospital chains, besides allowing them in strategizing investments and capitalizing on market opportunities.

Attribute

Details

Base Year

2021

Historic Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

  • Diagnostic Type
  • Technology
  • Application
  • End User

Country scope

China, India, Japan, South Korea, Australia, Singapore, Malaysia, Indonesia, Thailand & Philippines

Key companies profiled

Thermo Fisher Scientific, Inc., GE Healthcare (A Subsidiary of General Electric Company), Abbott Laboratories, Inc., Becton, Dickinson and Company, Siemens AG, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Bio Rad Laboratories Inc., Illumina, Inc., Boehringer-Ingelheim International GmbH.

Customization scope

10% free report customization with purchase. Addition or alteration to country, & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, Asia-Pacific cancer diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Asia-Pacific Cancer Diagnostics Market, By Diagnostic Type:
    • Lab Testing
    • Genetic Testing
    • Imaging Testing
    • Biomarkers Testing
    • In Vitro Diagnostic Testing
    • Biopsy
    • Others
  • Asia-Pacific Cancer Diagnostics Market, By Technology:
    • Platform Based
    • Instrument Based
    • Tumor Biomarker Tests
  • Asia-Pacific Cancer Diagnostics Market, By Application:
    • Lung Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Prostate Cancer
    • Kidney Cancer
    • Skin Cancer
    • Others
  • Asia-Pacific Cancer Diagnostics Market, By End-User:
    • Diagnostic Centers
    • Hospitals and Clinics
    • Research Institutes
    • Others
  • Asia Pacific Cancer Diagnostics Market, By Region:
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Indonesia
    • Philippines
    • Thailand

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Asia-Pacific cancer diagnostics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Asia-Pacific cancer diagnostics market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.     Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Asia-Pacific Cancer Diagnostics Market

4.    Executive Summary

5.    Voice of Customer

6.    Asia-Pacific Cancer Diagnostics Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Diagnostic Type (Lab Testing, Genetic Testing, Imaging Testing, Biomarkers Testing, In Vitro Diagnostic Testing, Biopsy and Others)

6.2.2.     By Technology (Platform Based, Instrument Based, Tumor Biomarker Tests)

6.2.3.     By Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Kidney Cancer, Skin cancer, Others)

6.2.4.     By End-User (Diagnostic Centers, Hospitals and Clinics, Research Institutes and Others)

6.2.5.     By Company

6.2.6.     By Country                   

6.3.  Product Market Map

6.4.  Asia-Pacific: Country Analysis

6.4.1.     China Cancer Diagnostics Market Outlook

6.4.1.1.         Market Size & Forecast

6.4.1.1.1.             By Value

6.4.1.2.         Market Share & Forecast

6.4.1.2.1.             By Diagnostic Type

6.4.1.2.2.             By Technology

6.4.1.2.3.             By Application

6.4.1.2.4.             By End User

6.4.2.     India Cancer Diagnostics Market Outlook

6.4.2.1.         Market Size & Forecast

6.4.2.1.1.             By Value

6.4.2.2.         Market Share & Forecast

6.4.2.2.1.             By Diagnostic Type

6.4.2.2.2.             By Technology

6.4.2.2.3.             By Application

6.4.2.2.4.             By End User

6.4.3.     Japan Cancer Diagnostics Market Outlook

6.4.3.1.         Market Size & Forecast

6.4.3.1.1.             By Value

6.4.3.2.         Market Share & Forecast

6.4.3.2.1.             By Diagnostic Type

6.4.3.2.2.             By Technology

6.4.3.2.3.             By Application

6.4.3.2.4.             By End User

6.4.4.     South Korea Cancer Diagnostics Market Outlook

6.4.4.1.         Market Size & Forecast

6.4.4.1.1.             By Value

6.4.4.2.         Market Share & Forecast

6.4.4.2.1.             By Diagnostic Type

6.4.4.2.2.             By Technology

6.4.4.2.3.             By Application

6.4.4.2.4.             By End User

6.4.5.     Australia Cancer Diagnostics Market Outlook

6.4.5.1.         Market Size & Forecast

6.4.5.1.1.             By Value

6.4.5.2.         Market Share & Forecast

6.4.5.2.1.             By Diagnostic Type

6.4.5.2.2.             By Technology

6.4.5.2.3.             By Application

6.4.5.2.4.             By End User

6.4.6.     Singapore Cancer Diagnostics Market Outlook

6.4.6.1.         Market Size & Forecast

6.4.6.1.1.             By Value

6.4.6.2.         Market Share & Forecast

6.4.6.2.1.             By Diagnostic Type

6.4.6.2.2.             By Technology

6.4.6.2.3.             By Application

6.4.6.2.4.             By End User

6.4.7.     Malaysia Cancer Diagnostics Market Outlook

6.4.7.1.         Market Size & Forecast

6.4.7.1.1.             By Value

6.4.7.2.         Market Share & Forecast

6.4.7.2.1.             By Diagnostic Type

6.4.7.2.2.             By Technology

6.4.7.2.3.             By Application

6.4.7.2.4.             By End User

6.4.8.     Indonesia Cancer Diagnostics Market Outlook

6.4.8.1.         Market Size & Forecast

6.4.8.1.1.             By Value

6.4.8.2.         Market Share & Forecast

6.4.8.2.1.             By Diagnostic Type

6.4.8.2.2.             By Technology

6.4.8.2.3.             By Application

6.4.8.2.4.             By End User

6.4.9.     Philippines Cancer Diagnostics Market Outlook

6.4.9.1.         Market Size & Forecast

6.4.9.1.1.             By Value

6.4.9.2.         Market Share & Forecast

6.4.9.2.1.             By Diagnostic Type

6.4.9.2.2.             By Technology

6.4.9.2.3.             By Application

6.4.9.2.4.             By End User

6.4.10.  Thailand Cancer Diagnostics Market Outlook

6.4.10.1.      Market Size & Forecast

6.4.10.1.1.           By Value

6.4.10.2.      Market Share & Forecast

6.4.10.2.1.           By Diagnostic Type

6.4.10.2.2.           By Technology

6.4.10.2.3.           By Application

6.4.10.2.4.           By End User

7.    Market Dynamics

7.1.  Drivers

7.2.  Challenges

8.    Market Trends & Developments

9.    Asia-Pacific Economic Profile

10.  Policy & Regulatory

11.  Competitive Landscape

11.1.              Thermo Fisher Scientific, Inc.

11.2.              GE Healthcare (A Subsidiary of General Electric Company)

11.3.              Abbott Laboratories, Inc.

11.4.              Becton, Dickinson and Company

11.5.              Siemens AG

11.6.              Agilent Technologies, Inc.

11.7.              F. Hoffmann-La Roche Ltd.

11.8.              Bio Rad Laboratories Inc.

11.9.              Illumina, Inc.

11.10.            Boehringer-Ingelheim International GmbH

12.  Strategic Recommendations

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com